Absci (ABSI) EBITDA Margin (2020 - 2026)
Absci's (ABSI) quarterly EBITDA Margin came in at 13900.47% in Q1 2026, down 1166781.0% year-on-year from N/an in Q1 2025, and down 206.58% quarter-over-quarter from 4534.0% in Q4 2025.
Absci (ABSI) EBITDA Margin (2020 - 2026) Analysis & Trends
Absci has disclosed EBITDA Margin across 7 years of filings, most recently posting 13900.47% for Q1 2026.
- EBITDA Margin for Q1 2026 came in at 13900.47%, down 1166781.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 6435.24% (down 420625.0% YoY), and the FY2025 annual result was 4092.43%, down 181909.0% from the prior year.
- EBITDA Margin came in at 13900.47% for Q1 2026 at Absci, down from 4534.0% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 1146.98% in Q3 2022 to a low of 16079.51% in Q4 2022.
- The 5-year median for EBITDA Margin is 2944.49% (2023), against an average of 4992.09%.
- Peak annual rise in EBITDA Margin reached 2743467 bps in 2022, while the deepest fall reached 1237347 bps in 2022.
- Absci's EBITDA Margin stood at 16079.51% in 2022, then surged by 57 bps to 6959.47% in 2023, then soared by 37 bps to 4396.69% in 2024, then slipped by 3 bps to 4534.0% in 2025, then tumbled by 207 bps to 13900.47% in 2026.
- The last three EBITDA Margin figures came in at 13900.47% (Q1 2026), 4534.0% (Q4 2025), and 7544.18% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | -13,900.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,900.47% |
| Dec 31, 2025 | -4,534.00% |
| Sep 30, 2025 | -7,544.18% |
| Jun 30, 2025 | -5,105.73% |
| Mar 31, 2025 | -2,232.65% |
| Dec 31, 2024 | -4,396.69% |
| Sep 30, 2024 | -1,589.24% |
| Jun 30, 2024 | -1,947.40% |
| Mar 31, 2024 | -2,457.68% |
| Dec 31, 2023 | -6,959.47% |
| Sep 30, 2023 | -2,944.49% |
| Jun 30, 2023 | -1,239.17% |
| Mar 31, 2023 | -1,838.46% |
| Dec 31, 2022 | -16,079.51% |
| Sep 30, 2022 | -1,146.98% |
| Jun 30, 2022 | -2,866.07% |
| Mar 31, 2022 | -8,083.29% |
| Dec 31, 2021 | -3,706.04% |
| Sep 30, 2021 | -1,700.58% |
| Jun 30, 2021 | -30,300.74% |